Tribody [(HER2)2xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells

詳細情報 詳細情報について

• CRID

  1360576121867786112

• DOI

  10.3389/fimmu.2018.00814

• ISSN

  16643224

• Web Site

  http://journal.frontiersin.org/article/10.3389/fimmu.2018.00814/full

• データソース種別

  • Crossref